European drugmakers urge leaders to restore pharma competitiveness
The letter said more than USD 600 billion in pharmaceutical investment had been announced in the US and China over the previous two years.
The chairs of nine major pharmaceutical companies urged European leaders to treat medicines as strategic infrastructure and take action to attract investment. They said Europe is losing ground to the US and China in pharmaceutical research, clinical trials and investment.
Claims
Support what holds up. Dispute what doesn't.
The chairs of nine pharmaceutical companies wrote to European national leaders calling for action to safeguard the companies’ future.
“The chairs of nine companies ... wrote to Andy Burnham and the national leaders of other European countries on Tuesday to call for action to “safeguard our companies’ future””
- 600BUSD
AllegedThe letter said more than USD 600 billion in pharmaceutical investment had been announced in the US and China over the previous two years.
“Over $600bn in pharmaceutical investment has been announced in the US and China in the last two years alone.”
- 220BEUR
The European Union’s pharmaceutical trade surplus exceeds EUR 220 billion.
“generating an EU trade surplus of more than €220bn”